We previously found that Ageladine A derivative 8a, a novel and highly effective inhibitor of SIRT6, can inhibit the activity of SIRT6 and has anti-pancreatic-cancer activity in vivo and in vitro. This evidence concerns the gene SIRT6 and pancreatic neoplasm.